Ausgabe 8/2006
Inhalt (10 Artikel)
Long-Acting β2-Agonists in Asthma
Graeme P. Currie, Daniel K.C. Lee, Brian J. Lipworth
Pharmacovigilance during the Pre-Approval Phases
Craig G. Hartford, Kasia S. Petchel, Hani Mickail, Susana Perez-Gutthann, Mary McHale, John M. Grana, Paula Marquez
Safety of Etanercept in Psoriasis
Jose L. Sánchez Carazo, Laura Mahiques Santos, Vicente Oliver Martinez
Serious Skin Reactions and Selective COX-2 Inhibitors
Deborah Layton, Vanessa Marshall, Andrew Boshier, Peter Friedmann, Saad AW Shakir
Can Decisional Algorithms Replace Global Introspection in the Individual Causality Assessment of Spontaneously Reported ADRs?
Ana F. Macedo, Francisco B. Marques, Carlos F. Ribeiro
Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in Plasma
Heiner K. Berthold, Ali Naini, Salvatore Di Mauro, Maarit Hallikainen, Helena Gylling, Wilhelm Krone, Ioanna Gouni-Berthold
Drug-Induced Thrombocytopenia
Maarten J. ten Berg, Albert Huisman, Patrick C. Souverein, Alfred F.A.M. Schobben, Antoine C.G. Egberts, Wouter W. van Solinge, Patricia M.L.A. van den Bemt
Clinical Risk Management in Dutch Community Pharmacies
Henk Buurma, Peter A.G.M De Smet, Antoine C.G. Egberts
An Industry Perspective on the Erice Declaration and Risk Minimisation Plans
Simon Ingate, Deborah Tranter, Anjan Banerjee, Andrew Hobbs